Monro Inc SEC Filings

Monro, Inc. (MNRO) posted a weak Q1 FY26 (13 weeks ended 28-Jun-25). Sales grew 2.7% to $301.0 mn as +5.7% comparable-store growth (all major categories positive) offset revenue lost from 145 store closures. Gross margin slid 170 bps to 35.5% on wage inflation and heavier tire promotions. OSG&A jumped 17.8% to 37.5% of sales, driven by $14.8 mn Store Closure Plan charges and $4.7 mn consulting fees tied to the AlixPartners Operational Improvement Plan.

Profitability deteriorated. GAAP operating swung to a $6.1 mn loss (vs. $13.2 mn income LY) and net loss reached $8.1 mn, or –$0.28/share (vs. $0.19). Adjusted EPS held flat at $0.22. Cash from operations was –$1.9 mn (LY +$25.6 mn) as payables timing reversed. Cash ended at $7.8 mn with $71.5 mn drawn on the revolver and $398.4 mn remaining capacity.

Balance-sheet actions. The fifth amendment permanently cut the revolver to $500 mn but lowered coverage covenants and dividend restrictions through Q1 FY27; min liquidity of $300 mn is required for dividends and M&A. Total liabilities declined 2.0% QoQ; long-term debt rose $10 mn. Dividend of $0.28/share was maintained.

Key forward issues: execution of the Store Closure Plan, realization of AlixPartners’ initiatives, and restoring positive operating cash flow while managing wage and material cost pressure.

The Vanguard Group filed Amendment No. 12 to Schedule 13G for Myriad Genetics, Inc. (MYGN) covering the period ended 30 Jun 2025.

• Beneficial ownership: 9,257,493 common shares, representing 10.04 % of outstanding stock.
• Voting power: 0 shares sole; 145,939 shares shared.
• Dispositive power: 9,003,551 shares sole; 253,942 shares shared.
• Filed under Rule 13d-1(b) as an investment adviser (IA); the holding is reported as passive and in the ordinary course of business.
• Crossing the 10 % threshold designates Vanguard as a 10 % beneficial owner, increasing disclosure and potential Section 16 obligations.

The filing signals continued, sizable institutional ownership but does not indicate any intent to influence control. Certification signed by Ashley Grim, Head of Global Fund Administration, on 29 Jul 2025.

Monro, Inc. (MNRO) has distributed Definitive Additional Proxy Materials for its 2025 Annual Meeting scheduled for August 12, 2025. Shareholders of record may vote online, by phone, by mail, or in-person, with Internet voting deadlines of August 11, 2025 11:59 p.m. ET (or August 7, 2025 for plan shares). The notice provides instructions for accessing the full proxy statement and 2025 Annual Report, or requesting paper/email copies by July 29, 2025.

The Board recommends voting “FOR” all management proposals:

• Item 1 – Election of eight directors (John L. Auerbach, Lindsay N. Hyde, Leah C. Johnson, Stephen C. McCluski, Robert E. Mellor, Thomas B. Okray, Peter J. Solomon, Hope B. Woodhouse) to serve until the 2026 annual meeting.
• Item 2 – Amendment to the 2007 Stock Incentive Plan to increase the number of shares available for issuance.
• Item 3 – Advisory “say-on-pay” vote on compensation of named executive officers.
• Item 4 – Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending March 28, 2026.
• Item 5 – Other business that may properly come before the meeting.

No financial performance data or transactional information is included in this DEFA14A; it serves solely as a voting notice and summary of agenda items.

Ranpak Holdings Corp. (NYSE: PACK) filed an 8-K announcing several executive changes.

Appointment of COO: The Board appointed Paul Aram (64) as Chief Operating Officer, effective upon his start date (to be mutually agreed). Aram joins from IDEX Corp., where he was Global Supply Chain & Operations Director (Jan-2024‒Present) and previously served as VP Global Operations at Ingersoll Rand (2019-2023). Key compensation terms include:

• Annual base salary: €310,000
• Target cash bonus: 40 % of base salary
• One-time equity grant: 5,000 PRSUs + 5,000 RSUs

The employment agreement (Exhibit 10.1) allows for future salary/bonus review and standard senior-executive benefits.

Departures of Regional Managing Directors:

• Eric Laurensse, Managing Director – Europe, will depart 1 Aug 2025.
• Antonio Grassotti, Managing Director – APAC, will depart 31 Jul 2025.

Both executives signed separation agreements (Exhibits 10.2 & 10.3). Their outstanding equity awards will continue to vest:

• Laurensse: 76,641 RSUs scheduled to vest in 2026
• Grassotti: 49,965 RSUs scheduled to vest in 2026

The company states there are no disagreements concerning operations, policies, or practices related to these departures.

Investor implications: The hiring of an experienced operations leader may strengthen global supply-chain efficiency, but simultaneous exits of two regional heads introduce transition risk in EMEA and APAC markets. No immediate financial guidance or earnings impact was disclosed.